Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Glaxo ViiV Healthcare CEO Sells GBP294,000 Worth Of Shares

4th Nov 2020 20:19

GlaxoSmithKline PLC - FTSE 100-listed pharmaceutical company - Says ViiV Healthcare Chief Executive Deborah Waterhouse sold 21,828 shares at a price of 1,346.10 pence each on Tuesday. Transaction worth GBP293,827. ViiV Healthcare is majority owned by GSK, with Pfizer Inc and Shionogi Ltd as shareholders.

Current stock price: 1,415.00 pence

Year-to-date change: down 20%

By Lucy Heming; [email protected]

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,328.60
Change0.00